137 related articles for article (PubMed ID: 34259934)
1. Computational study on novel natural inhibitors targeting BCL2.
Lv X; Jiang Y; Wang X; Xie H; Dou G; Wang J; Yang W; Wang H; Li Z; Zhang X; Chen Z
Med Oncol; 2021 Jul; 38(8):94. PubMed ID: 34259934
[TBL] [Abstract][Full Text] [Related]
2. Computational Study of Novel Natural Inhibitors Targeting O
Yang L; Li W; Zhao Y; Zhong S; Wang X; Jiang S; Cheng Y; Xu H; Zhao G
World Neurosurg; 2019 Oct; 130():e294-e306. PubMed ID: 31203065
[TBL] [Abstract][Full Text] [Related]
3. Computational study on novel natural inhibitors targeting c-MET.
Hou Y; Xie H; Dou G; Yang W; Ge J; Zhou B; Ren J; Li J; Wang J; Zhang Z; Wang X
Medicine (Baltimore); 2021 Sep; 100(38):e27171. PubMed ID: 34559105
[TBL] [Abstract][Full Text] [Related]
4. Effective natural inhibitors targeting poly ADP-ribose polymerase by computational study.
Zhong S; Wu B; Yang W; Ge J; Zhang X; Chen Z; Duan H; He Z; Liu Y; Wang H; Jiang Y; Zhang Z; Wang X; Li W; Liu N; Guo X; Mou Y
Aging (Albany NY); 2021 Jan; 13(2):1898-1912. PubMed ID: 33486472
[TBL] [Abstract][Full Text] [Related]
5. Computational study on natural compounds inhibitor of c-Myc.
Ren J; Huangfu Y; Ge J; Wu B; Li W; Wang X; Zhao L
Medicine (Baltimore); 2020 Dec; 99(50):e23342. PubMed ID: 33327259
[TBL] [Abstract][Full Text] [Related]
6. Computational study on new natural compound agonists of stimulator of interferon genes (STING).
Zhong S; Li W; Bai Y; Wu B; Wang X; Jiang S; Zhao Y; Ren J; Li H; Jin R
PLoS One; 2019; 14(5):e0216678. PubMed ID: 31120925
[TBL] [Abstract][Full Text] [Related]
7. Computational study of novel natural inhibitors targeting aminopeptidase N(CD13).
Ge J; Wang Z; Cheng Y; Ren J; Wu B; Li W; Wang X; Su X; Liu Z
Aging (Albany NY); 2020 May; 12(9):8523-8535. PubMed ID: 32388498
[TBL] [Abstract][Full Text] [Related]
8. Effective natural inhibitors targeting IGF-1R by computational study.
Wang X; Zhou P; Lin L; Wu B; Fu Z; Huang X; Zhu D
Aging (Albany NY); 2022 Jun; 14(11):4874-4887. PubMed ID: 35680570
[TBL] [Abstract][Full Text] [Related]
9. Novel natural inhibitors targeting KRAS G12C by computational study.
Jiang Y; Chen W; Wang X; Zhou B; Xie H; Hou Y; Guo Z; Yu B; Zhong S; Su X
Anticancer Drugs; 2022 Oct; 33(9):779-788. PubMed ID: 35980001
[TBL] [Abstract][Full Text] [Related]
10. Computational study of effective matrix metalloproteinase 9 (MMP9) targeting natural inhibitors.
Liu N; Wang X; Wu H; Lv X; Xie H; Guo Z; Wang J; Dou G; Zhang C; Sun M
Aging (Albany NY); 2021 Oct; 13(19):22867-22882. PubMed ID: 34607974
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel natural inhibitors targeting AKT Serine/Threonine Kinase 1 (AKT1) by computational study.
Zhong S; Zhang Z; Guo Z; Yang W; Dou G; Lv X; Wang X; Ge J; Wu B; Pan X; Wang H; Mou Y
Bioengineered; 2022 May; 13(5):12003-12020. PubMed ID: 35603567
[TBL] [Abstract][Full Text] [Related]
12. Novel natural inhibitors targeting B-RAF(V600E) by computational study.
Wu B; Zhang Z; Dou G; Lv X; Ge J; Wang H; Xie H; Zhu D
Bioengineered; 2021 Dec; 12(1):2970-2983. PubMed ID: 34252351
[TBL] [Abstract][Full Text] [Related]
13. Virtual Screening of Small Molecules Targeting BCL2 with Machine Learning, Molecular Docking, and MD Simulation.
Tondar A; Sánchez-Herrero S; Bepari AK; Bahmani A; Calvet Liñán L; Hervás-Marín D
Biomolecules; 2024 May; 14(5):. PubMed ID: 38785951
[TBL] [Abstract][Full Text] [Related]
14. GNA13 regulates BCL2 expression and the sensitivity of GCB-DLBCL cells to BCL2 inhibitors in a palmitoylation-dependent manner.
Xia Z; Zhang X; Liu P; Zhang R; Huang Z; Li D; Xiao X; Wu M; Ning N; Zhang Q; Zhang J; Liu M; Jiao B; Ren R
Cell Death Dis; 2021 Jan; 12(1):54. PubMed ID: 33423045
[TBL] [Abstract][Full Text] [Related]
15. Selected by bioinformatics and molecular docking analysis, Dhea and 2-14,15-Eg are effective against cholangiocarcinoma.
Qin L; Kuai J; Yang F; Yang L; Sun P; Zhang L; Li G
PLoS One; 2022; 17(2):e0260180. PubMed ID: 35113866
[TBL] [Abstract][Full Text] [Related]
16. Phytosterols and triterpenes from
Adewole KE; Ishola AA
J Recept Signal Transduct Res; 2019 Feb; 39(1):87-97. PubMed ID: 31215288
[TBL] [Abstract][Full Text] [Related]
17. Selective targeting of BCL6 induces oncogene addiction switching to BCL2 in B-cell lymphoma.
Dupont T; Yang SN; Patel J; Hatzi K; Malik A; Tam W; Martin P; Leonard J; Melnick A; Cerchietti L
Oncotarget; 2016 Jan; 7(3):3520-32. PubMed ID: 26657288
[TBL] [Abstract][Full Text] [Related]
18. Structure-based screening and molecular dynamics simulations offer novel natural compounds as potential inhibitors of Mycobacterium tuberculosis isocitrate lyase.
Shukla R; Shukla H; Sonkar A; Pandey T; Tripathi T
J Biomol Struct Dyn; 2018 Jun; 36(8):2045-2057. PubMed ID: 28605994
[TBL] [Abstract][Full Text] [Related]
19. Targeting BCL2 with venetoclax is a promising therapeutic strategy for "double-proteinexpression" lymphoma with
Uchida A; Isobe Y; Asano J; Uemura Y; Hoshikawa M; Takagi M; Miura I
Haematologica; 2019 Jul; 104(7):1417-1421. PubMed ID: 30523053
[TBL] [Abstract][Full Text] [Related]
20. Computational study on new natural compound inhibitors of Traf2 and Nck-interacting kinase (TNIK).
Ma L; Li R; Yao Z; Wang B; Liu Y; Liu C; Wang H; Chen S; Sun D
Aging (Albany NY); 2022 Oct; 14(20):8394-8410. PubMed ID: 36287174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]